Nexus Surgical and Medicare LI
BSE: NEXUSSURGL · Other Financial Services · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 96 companies in Other Financial Services (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Other income was 8% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹23.80 on 2026-10-26: -33.5% from the 52-week high, +79.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 1 | 2 | 1 | 3 | 2 | 3 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
| OPM % | 7.4% | 11.6% | 19.7% | 7.8% | 14.6% | 9.8% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (₹) | 0.16 | 0.28 | 0.32 | 0.31 | 0.44 | 0.37 |
| Revenue YoY | +38.5% | +47.4% | ||||
| Profit YoY | +166.7% | +33.3% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 3 | 6 | 8 | 9 |
| EBITDA | 0 | 0 | 0 | 1 | 1 | 1 |
| Net profit | 0 | 0 | 0 | 0 | 1 | 1 |
| EPS (₹) | 0.53 | 0.31 | 0.39 | 0.91 | 1.35 | 1.44 |
| Revenue growth | -35.4% | +123.9% | +64.8% | +37.6% | – | |
| Profit growth | -41.4% | +23.5% | +138.1% | +48.0% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +71.9% | – | – |
| Net profit | +63.0% | – | – |
| EPS | +63.3% | – | – |
| Share price | – | +23.9% (2y) | +53.3% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 1 | 2 |
| Borrowings | 0 | 0 |
| Cash & equivalents | 0 | 0 |
| Total assets | 2 | 4 |
| Fixed assets | 0 | 0 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 1 | 1 |
| Inventory | 0 | 0 |
| Payables | 1 | 2 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 0 | 0 |
| Cash from investing | -0 | 0 |
| Cash from financing | 0 | 0 |
| Capex | 0 | 0 |
| Free cash flow | 0 | 0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 46.8% | 40.9% |
| ROCE % | 62.8% | 54.9% |
| Debtor days | 85 | 61 |
| Inventory days | 84 | 54 |
| Payable days | 230 | 238 |
| Cash conversion cycle (days) | -61 | -123 |
| Working capital days | 66 | 82 |
Peers in Other Financial Services
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| ARCFIN | ₹37,47,491 cr | 43.0x | 37,875.8x | 0.8% | – | – | +66.4% | – |
| CRISIL | ₹34,926 cr | 39.5x | 10.7x | 29.1% | – | 29.8% | – | – |
| RRP | ₹10,960 cr | 1,406.3x | 1,211.9x | -60.1% | -47.5% | 105.2% | – | – |
| ARCIL | ₹3,972 cr | – | – | – | – | – | – | – |
| KISSHT | ₹3,472 cr | 6.5x | 2.6x | 21.0% | – | 29.9% | – | – |
| GYFTR | ₹1,229 cr | – | – | – | – | – | – | – |
| PRIMESECU | ₹929 cr | 35.5x | 4.4x | 13.2% | – | – | +23.5% | 0.54% |
| CENTRUM | ₹860 cr | – | 2.8x | -73.4% | – | – | +42.1% | – |
| REGENCY | ₹565 cr | 23.9x | 3.0x | 14.1% | – | – | +277.6% | – |
| NEXUSSURGL | ₹13 cr | 16.5x | 7.2x | 55.0% | 58.7% | 11.6% | +71.9% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Financial Services |
| Industry | Other Financial Services |
| Sub-industry | Other Financial Services |
| Symbol | NEXUSSURGL |
| BSE code | 538874 |
| ISIN | INE370Q01015 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.